Heart Failure with Myocardial Recovery - The Patient Whose Heart Failure Has Improved: What Next?

被引:29
作者
Nijst, Petra [1 ,2 ]
Martens, Pieter [1 ,2 ]
Mullens, Wilfried [1 ,3 ]
机构
[1] Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium
[2] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium
[3] Hasselt Univ, Biomed Res Inst, Fac Med & Life Sci, Diepenbeek, Belgium
关键词
Heart failure with recovered ejection fraction; Myocardial recovery; Reverse remodeling; CARDIAC-RESYNCHRONIZATION THERAPY; VENTRICULAR EJECTION FRACTION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CONVERTING-ENZYME-INHIBITOR; BRAIN NATRIURETIC PEPTIDE; LONG-TERM; SYSTOLIC DYSFUNCTION; ASSIST DEVICE; DOUBLE-BLIND; EXERCISE CAPACITY;
D O I
10.1016/j.pcad.2017.05.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In an important number of heart failure (HF) patients substantial or complete myocardial recovery occurs. In the strictest sense, myocardial recovery is a return to both normal structure and function of the heart. HF patients with myocardial recovery or recovered ejection fraction (EF; HFrecEF) are a distinct population of HF patients with different underlying etiologies, demographics, comorbidities, response to therapies and outcomes compared to HF patients with persistent reduced (HFrEF) or preserved ejection fraction (HFpEF). Improvement of left ventricular EF has been systematically linked to improved quality of life, lower rehospitalization rates and mortality. However, mortality and morbidity in HFrecEF patients remain higher than in the normal population. Also, persistent abnormalities in biomarker and gene expression profiles in these patients lends weight to the hypothesis that pathological processes are ongoing. Currently, there remains a lack of data to guide the management of HFrecEF patients. This review will discuss specific characteristics, pathophysiology, clinical implications and future needs for HFrecEF. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:226 / 236
页数:11
相关论文
共 123 条
  • [1] Peripartum cardiomyopathy: A comprehensive review
    Abboud, John
    Murad, Yahya
    Chen-Scarabelli, Carol
    Saravolatz, Louis
    Scarabelli, Tiziano M.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 118 (03) : 295 - 303
  • [2] Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure
    Abraham, WT
    Young, JB
    León, AR
    Adler, S
    Bank, AJ
    Hall, SA
    Lieberman, R
    Liem, LB
    O'Connell, JB
    Schroeder, JS
    Wheelan, KR
    [J]. CIRCULATION, 2004, 110 (18) : 2864 - 2868
  • [3] Modulation of Mitochondrial Proteome and Improved Mitochondrial Function by Biventricular Pacing of Dyssynchronous Failing Hearts
    Agnetti, Giulio
    Kaludercic, Nina
    Kane, Lesley A.
    Elliott, Steven T.
    Guo, Yurong
    Chakir, Khalid
    Samantapudi, Daya
    Paolocci, Nazareno
    Tomaselli, Gordon F.
    Kass, David A.
    Van Eyk, Jennifer E.
    [J]. CIRCULATION-CARDIOVASCULAR GENETICS, 2010, 3 (01) : 78 - U273
  • [4] Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support
    Ahmad, Tariq
    Kelly, Jacob P.
    McGarrah, Robert W.
    Hellkamp, Anne S.
    Fiuzat, Mona
    Testani, Jeffrey M.
    Wang, Teresa S.
    Verma, Amanda
    Samsky, Marc D.
    Donahue, Mark P.
    Ilkayeva, Olga R.
    Bowles, Dawn E.
    Patel, Chetan B.
    Milano, Carmelo A.
    Rogers, Joseph G.
    Felker, G. Michael
    O'Connor, Christopher M.
    Shah, Svati H.
    Kraus, William E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (03) : 291 - 299
  • [5] Amorim S, 2016, INT J CARDIOVASC IMA
  • [6] [Anonymous], 2016, EUR HEART J
  • [7] EFFECTS OF ADDING SPIRONOLACTONE TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE
    BARR, CS
    LANG, CC
    HANSON, J
    ARNOTT, M
    KENNEDY, N
    STRUTHERS, AD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17) : 1259 - 1265
  • [8] Basu S, 1997, CIRCULATION, V96, P183
  • [9] Management of Patients With Recovered Systolic Function
    Basuray, Anupam
    Fang, James C.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 58 (04) : 434 - 443
  • [10] Heart Failure With Recovered Ejection Fraction Clinical Description, Biomarkers, and Outcomes
    Basuray, Anupam
    French, Benjamin
    Ky, Bonnie
    Vorovich, Esther
    Olt, Caroline
    Sweitzer, Nancy K.
    Cappola, Thomas P.
    Fang, James C.
    [J]. CIRCULATION, 2014, 129 (23) : 2380 - 2387